Biochemical Engineering
Novavax snares $167M buyout to rapidly scale up COVID-19 vaccine manufacturing
27th May 2020
In its pursuit of a COVID-19 vaccine, Novavax bagged a major cash infusion earlier this month thanks to a nearly $400 million grant from a global epidemic response fund. Now, Novavax has put some of those funds to good use in an effort to supercharge its manufacturing capacity.
Novavax will fork over $167 million for Czech manufacturer Praha Vaccines and team up with vaccine giant Serum Institute of India in moves that will add capacity for 1 billion-plus doses per year of a potential COVID-19 shot, the drugmaker said Wednesday. Source: Fierce Pharma 27/5/2020
Back to group news